AURX today
$1.01+$0.11 (+11.64%)close Jun 25, 2026Trend
—
Key levels
—
Latest news & SEC filings
SEC FilingNuo Therapeutics, Inc. filed an insider trading report (Form 4)
All AURX news →OTC · Healthcare
Nuo Therapeutics, Inc. (AURX)
What Is the Price Target for AURX?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is AURX a Buy or Sell Right Now?
Thesis
- •Revenue growing 142.7% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AURX.
Start Free Trial →Is AURX Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, PEG
Fair Value
$0.66
33
Moat Score
NONE
2/9
Piotroski Score
-10.0
Altman Z-Score
What Is Smart Money Doing with AURX?
Insider Signal
NEUTRAL
2 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| JORDEN DAVID EMERSON | director officer | Buy | 7,984 | $9K | Aug 28, 2026 |
| JORDEN DAVID EMERSON | director officer | Buy | 7,984 | $9K | Aug 28, 2026 |
| JORDEN DAVID EMERSON | director officer | Buy | 789 | $844.23 | Aug 27, 2026 |
| JORDEN DAVID EMERSON | director officer | Buy | 789 | $844.23 | Aug 27, 2026 |
| JORDEN DAVID EMERSON | director officer | Buy | 13,245 | $15K | Jun 5, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AURX Growth Story
Revenue YoY
142.7%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
52.2%
Revenue Trend
ACCELERATING
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Nuo Therapeutics, Inc. (AURX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AURX — frequently asked questions
What is AURX stock price today?
Nuo Therapeutics, Inc. (AURX) is at $1.01, up 11.64% (+$0.11) at the Jun 25, 2026 close.
Why is AURX stock moving today?
Latest AURX news — Oct 6, 2026: Nuo Therapeutics, Inc. filed an insider trading report (Form 4)
Does AURX pay a dividend?
AURX does not currently pay a dividend.
What are insiders doing with AURX?
Insider activity: NEUTRAL, 2 buys and 0 sells in the last 90 days.
What is the latest news on AURX?
Oct 6, 2026: Nuo Therapeutics, Inc. filed an insider trading report (Form 4)